Stevanato Group S.p.A (STVN) Total Current Liabilities (2020 - 2025)
Stevanato Group S.p.A (STVN) reported Total Current Liabilities of $623.8 million for Q4 2025, up 22.26% year-over-year from $510.2 million in Q4 2024, and up 22.26% quarter-over-quarter from $510.2 million in Q4 2024.
Stevanato Group S.p.A (STVN) Total Current Liabilities (2020 - 2025) Analysis & Trends
Stevanato Group S.p.A (STVN) has 6 years of Total Current Liabilities data on file, last reported at $623.8 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $623.8 million, up 22.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $623.8 million (up 22.26% YoY), and the FY2025 annual result was $623.8 million, up 22.26% from the prior year.
- Total Current Liabilities grew to $623.8 million in Q4 2025 per STVN's latest filing, from $510.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $623.8 million in Q4 2025 and troughed at $386.3 million in Q3 2021.
- A 5-year average of $485.2 million and a median of $471.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities jumped 30.97% in 2023, then decreased 17.44% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $387.4 million in 2021, then increased by 21.81% to $471.9 million in 2022, then jumped by 30.97% to $618.0 million in 2023, then declined by 17.44% to $510.2 million in 2024, then gained by 22.26% to $623.8 million in 2025.
- Business Quant data shows STVN's Total Current Liabilities at $623.8 million in Q4 2025, $510.2 million in Q4 2024, and $618.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 623.79 Mn |
| Dec 31, 2024 | 510.23 Mn |
| Dec 31, 2023 | 618.01 Mn |
| Dec 31, 2022 | 471.87 Mn |
| Dec 31, 2021 | 387.37 Mn |
| Sep 30, 2021 | 386.33 Mn |
| Jun 30, 2021 | 398.71 Mn |
| Dec 31, 2020 | 376.97 Mn |